Diabetic neuropathy typically takes at least 10 years to develop noticeable symptoms in people with type 1 diabetes, but it can already be present at the time of a type 2 diabetes diagnosis. Around 8% of people newly diagnosed with type 2 diabetes already show signs of nerve damage, and that number climbs past 50% in those who have lived with diabetes for many years. The timeline varies widely depending on how well blood sugar is controlled and several other risk factors.
The Timeline Differs by Diabetes Type
In type 1 diabetes, neuropathy rarely appears at the moment of diagnosis. It typically emerges after at least 10 years with the disease and can affect up to 34% of people after roughly 25 years. Data from the landmark DCCT/EDIC study found that neuropathy prevalence among adults with type 1 diabetes was 6% at baseline and rose to 30% after 13 to 14 years of follow-up. This is why the American Diabetes Association recommends that people with type 1 diabetes begin annual neuropathy screening five years after diagnosis.
Type 2 diabetes follows a very different pattern. Because type 2 often goes undiagnosed for years, nerve damage may already be underway before anyone catches the diabetes itself. Screening starts immediately at diagnosis for type 2, not after a waiting period. In a large French cohort study that followed 4,400 adults with diabetes over 25 years, half eventually developed peripheral neuropathy by the end of the study period.
Nerve Damage Starts Before You Feel It
One of the most important things to understand about the timeline is that there are two phases: a silent phase and a symptomatic phase. Up to one-third of people with type 2 diabetes already have measurable nerve conduction abnormalities at the time of diagnosis, even though they feel perfectly fine. These electrical signals traveling through your nerves slow down before you ever notice tingling or numbness. This gap between detectable damage and noticeable symptoms can last years, which is why regular screening matters even if your feet feel normal.
Nerve conduction studies can pick up these early, subclinical changes well before a standard physical exam would reveal anything. By the time symptoms show up on a clinical exam, the damage has often been progressing for a while.
What the Earliest Symptoms Feel Like
The first signs are usually subtle. Decreased sensitivity to light touch and loss of ankle reflexes tend to appear earliest in the disease process. From there, symptoms progress to burning, numbness, or tingling in the feet, often worse at night. About 80% of people with diabetic neuropathy experience what’s called a “stocking-glove distribution,” where symptoms start in the toes and feet, then gradually creep upward toward the ankles and calves, and eventually reach the hands. This pattern takes several years to fully develop.
Some people also experience aching, weakness in the limbs, or heightened pain sensitivity where even a bedsheet brushing against the skin feels uncomfortable. These symptoms often make walking and daily activities harder over time.
How High Blood Sugar Damages Nerves
The underlying process isn’t a single event but a slow cascade of damage driven by prolonged high blood sugar. When glucose levels stay elevated, excess sugar gets converted into a compound called sorbitol inside nerve cells. Sorbitol doesn’t cross cell membranes easily, so it builds up, drawing in water and swelling the cells. At the same time, this buildup depletes the cell’s energy reserves and disrupts its ability to function normally.
Meanwhile, sugar molecules attach to proteins throughout the nerve tissue, forming sticky deposits in the nerve fibers, their protective coating cells, and the tiny blood vessels that supply them. These deposits trigger inflammation and generate harmful molecules called free radicals. The combination of energy-starved nerve cells, inflamed tissue, and damaged blood vessels creates a slow, compounding injury. Mitochondria, the energy-producing structures inside cells, become overwhelmed by excess glucose and start producing oxidants instead of energy, further weakening the nerves. This explains why the damage accumulates gradually over years rather than happening all at once.
The A1c Threshold That Matters
Blood sugar control is the single biggest factor determining how quickly neuropathy develops. Research on patients with type 2 diabetes found that the A1c level separating those who developed neuropathy from those who didn’t was approximately 6.5% to 7.0%. In the study, 52% of people with neuropathy had a mean A1c of 7.0% or higher, compared to only 37.5% of those without neuropathy.
After adjusting for other patient characteristics, the more precise cutoff was an A1c of about 7.1%, with reasonable accuracy in predicting who would go on to develop nerve damage. This doesn’t mean neuropathy is impossible below that number, but the risk increases meaningfully above it. Every sustained period of elevated blood sugar adds to the cumulative nerve injury.
Other Factors That Speed Up the Timeline
Blood sugar isn’t the only variable. Several conditions common in people with diabetes can accelerate nerve damage independently. High blood pressure damages the small blood vessels that feed nerves, reducing their oxygen supply. Obesity increases systemic inflammation, which compounds the inflammatory damage already happening in nerve tissue. Smoking constricts blood vessels and further starves nerves of nutrients and oxygen. High cholesterol and triglycerides also contribute to vascular damage around the nerves.
Someone with poorly controlled blood sugar, high blood pressure, and a smoking habit will almost certainly develop neuropathy faster than someone who manages all three. The timeline isn’t fixed by diagnosis alone. It’s shaped by the metabolic environment your nerves live in every day.
What Screening Looks Like
Annual neuropathy screening is straightforward. It typically involves testing your ability to feel a thin filament pressed against the bottom of your foot, checking your ankle reflexes, and assessing vibration sensation using a tuning fork. These simple tests catch the majority of cases. If results are borderline or your doctor suspects early damage, nerve conduction studies can measure how fast electrical signals travel through your nerves and detect problems long before they produce symptoms.
The American Diabetes Association recommends annual screening starting at diagnosis for type 2 diabetes and five years after diagnosis for type 1. If you also have kidney disease or other complications involving small blood vessels, screening for autonomic neuropathy (which affects heart rate, digestion, and other involuntary functions) should begin on the same schedule.